News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
79 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17781)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
2 (104)
3 (173)
4 (173)
5 (128)
6 (1)
7 (23)
8 (258)
9 (151)
10 (98)
11 (90)
12 (52)
13 (1)
14 (1)
15 (70)
16 (158)
17 (130)
18 (132)
19 (69)
20 (4)
21 (3)
22 (130)
23 (153)
24 (124)
25 (141)
26 (79)
27 (1)
28 (1)
29 (133)
30 (155)
31 (147)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Deals
resTORbio Scores $85M IPO
The offering is expected to close on January 30, 2018, subject to customary closing conditions.
January 26, 2018
·
2 min read
Biotech Bay
Anthera Receives Positive Nasdaq Listing Determination
Anthera’s continued listing on The Nasdaq Capital Market is subject to compli
January 26, 2018
·
1 min read
Business
Fluidigm to Report Q4 and Full Year 2017 Financial Results
A press release outlining the financial results will be publicly distributed before the call.
January 26, 2018
·
2 min read
Pharm Country
Insmed Announces Closing of Public Offering - Jan. 26, 2018
The net proceeds to Insmed from the offering were approximately $435.8 million, after deducting underwriting discounts and commissions and other estimated offering expenses payable by Insmed.
January 26, 2018
·
10 min read
Medtronic Launches IDE Study to Evaluate the Abre Venous Self-Expanding Stent System in Patients With Deep Venous Disease
The multi-center, single arm study intends to enroll 200 subjects with deep venous disease from up to 35 sites throughout the U.S. and Europe.
January 26, 2018
·
4 min read
Business
Adverum Biotechnologies and Editas Medicine Extend Research Collaboration
The companies established this collaboration to explore the delivery of genome editing medicines to treat up to five inherited retinal diseases.
January 26, 2018
·
4 min read
Business
Intuitive Surgical Announces Fourth Quarter Earnings
Reported revenue and procedure results are consistent with the Company’s press release on January 10, 2018.
January 26, 2018
·
18 min read
Business
Adherium Names Tim Houchin Vice President of Sales
The addition of a senior executive of Tim’s caliber is another proof point as we advance our strategy to meet U.S. demand
January 26, 2018
·
1 min read
FDA
Perrigo Announces Tentative FDA Approval for the Generic Version of Onexton Gel
Onexton Gel is a prescription medicine indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.
January 26, 2018
·
4 min read
Previous
8 of 8